Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Switch Biotech files patent applications for wound-healing genes

Feb. 23, 2000

Topical tazarotene effective in congenital ichthyosis

Feb. 18, 2000

Antipsoriatic activity of EGF receptor tyrosine kinase inhibitor SU-5271

Feb. 15, 2000

Clearance to begin clinical trial of novel acne treatment sought by Praxis

Feb. 14, 2000

Hair growth promoter described by BMS for use in male pattern baldness

Feb. 9, 2000

Methods of wound healing using amphipathic peptides from Demegen

Feb. 8, 2000

New Sumitomo compounds inhibit cytokine and IgE production

Feb. 8, 2000

Cellegy to commence phase II trial of Anogesic as hemorrhoid treatment

Feb. 8, 2000

Alexion to commence development of 5G1.1 for treatment of dermatomyositis

Feb. 3, 2000

IGI and Fujisawa collaborate on topical formulations of dermatological product

Jan. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...